Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Earnings Data
Report Date
Apr 24, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
2.38Last Year’s EPS
2.13Same Quarter Last Year
Moderate Buy
Based on 12 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Jan 30, 2025
|% Change Since: -9.44%
|Next Earnings Date:Apr 24, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong financial performance with significant growth in revenue, device sales, and earnings per share. The company highlighted successful product innovations and strategic collaborations. Despite some currency-related revenue impacts and potential tariff concerns, the overall sentiment remains positive with a focus on sustained growth and innovation.Company Guidance
During the Q2 Fiscal Year 2025 earnings call, ResMed provided a robust financial overview, highlighting a 10% global revenue growth and a 29% increase in non-GAAP earnings per share. The company achieved a 230 basis point expansion in gross margins to 59.2%, driven by manufacturing efficiencies and cost improvements. Device sales grew in double digits, with strong performances across the U.S., Europe, and Asia, notably bolstered by the AirSense 10 and AirSense 11 platforms. The masks and accessories business also experienced double-digit growth. ResMed maintained disciplined investments, allocating 6% to 7% of revenues to R&D, contributing to their ongoing product innovation and market leadership. The call underscored the potential impacts of emerging trends such as GLP-1 pharmaceuticals and consumer wearables on patient flow and ResMed's strategic positioning to capitalize on these opportunities over the coming quarters and years.Strong Revenue Growth
ResMed delivered global revenue growth of 10%, driven by strong market performance across regions, particularly in the U.S., Canada, and Latin America with a 12% increase.
Device and Mask Sales Growth
Device sales increased by 11% globally, with strong demand for AirSense 10 and AirSense 11 platforms. Masks and accessories also saw double-digit global growth.
Gross Margin Expansion
ResMed achieved 230 basis points of margin expansion in non-GAAP gross margin year-over-year to 59.2%, indicating improved operating efficiencies.
Earnings Per Share Increase
Non-GAAP earnings per share increased by 29% year-over-year, reflecting strong financial performance.
Innovation and Product Launches
Launched AirTouch N30i with unique fabric-based patient interface and announced collaboration with Apple for a premium accessory for the Apple Vision Pro.
Strong Performance in Residential Care Software
Residential care software revenue increased by 8%, driven by strong performance from the MEDIFOX DAN software vertical.
Cash Flow and Share Buyback
Cash flow from operations for the quarter was $309 million, with a share buyback program offsetting equity dilution.
---
RMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
RMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 30, 2025 | $257.07 | $235.65 | -8.33% |
| Oct 24, 2024 | $238.00 | $254.94 | +7.12% |
| Aug 01, 2024 | $213.11 | $222.13 | +4.23% |
| Apr 25, 2024 | $181.77 | $216.10 | +18.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Resmed (RMD) report earnings?
Resmed (RMD) is schdueled to report earning on Apr 24, 2025, TBA Not Confirmed.
What is Resmed (RMD) earnings time?
Resmed (RMD) earnings time is at Apr 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RMD EPS forecast?
RMD EPS forecast for the fiscal quarter 2025 (Q3) is 2.38.
---